Systems Analysis of Arrestin Pathway Functions - Progress in Molecular Biology and Translational Science - page 448

62. Martin B, Brenneman R, Golden E, et al. Growth factor signals in neural cells: coherent
patterns of interaction control multiple levels of molecular and phenotypic responses.
J Biol Chem . 2009;284:2493- 2511.
63. Hunter T. Signaling - 2000 and beyond. Cell . 2000;100:113- 127.
64. Schlessinger J. Cell signaling by receptor tyrosine kinases. Cell . 2000;103:211- 225.
65. Diviani D, Baisamy L, Appert-Collin A. AKAP-Lbc: a molecular scaffold for the inte-
gration of cyclic AMP and Rho transduction pathways. Eur J Cell Biol .

2006;85:603- 610.
66. Tapon N, Nagata K, Lamarche N, Hall A. A new rac target POSH is an SH3-
containing scaffold protein involved in the JNK and NF-kappaB signaling pathways.
EMBO J . 1998;17:1395- 1404.
67. Dickens M, Rogers JS, Cavanagh J, et al. A cytoplasmic inhibitor of the JNK signal
transduction pathway. Science . 1997;277:693- 696.
68. Shinoda S, Skradski SL, Araki T, et al. Formation of a tumour necrosis factor receptor 1
molecular scaffolding complex and activation of apoptosis signal-regulating kinase 1
during seizure-induced neuronal death. Eur J Neurosci . 2003;17:2065 - 2076.
69. Willoughby EA, Collins MK. Dynamic interaction between the dual specificity phos-
phatase MKP7 and the JNK3 scaffold protein beta-arrestin 2. J Biol Chem .

2005;280:25651 - 25658.
70. Maudsley S, Davidson L, Pawson AJ, et al. Gonadotropin-releasing hormone function-
ally antagonizes testosterone activation of the human androgen receptor in prostate cells
through focal adhesion complexes involving Hic-5. Neuroendocrinology . 2006;

84:285 - 300.
71. Maudsley S, Naor Z, Bonfil D, et al. Proline-rich tyrosine kinase 2 mediates
gonadotropin-releasing hormone signaling to a specific extracellularly regulated
kinase-sensitive transcriptional locus in the luteinizing hormone beta-subunit gene.
Mol Endocrinol . 2007;21:1216- 1233.
72. Maudsley S, Martin B, Luttrell LM. G protein-coupled receptor signaling complexity
in neuronal tissue: implications for novel therapeutics. Curr Alzheimer Res .

2007;4:3- 19.
73. Song X, Coffa S, Fu H, Gurevich VV. How does arrestin assemble MAPKs into a sig-
naling complex? J Biol Chem . 2009;284:685 - 695.
74. Daaka Y, Luttrell LM, Ahn S, et al. Essential role for G protein-coupled receptor endo-
cytosis in the activation of mitogen-activated protein kinase. J Biol Chem .

1998;273:685- 688.
75. Li X, MacLeod R, Dunlop AJ, et al. A scanning peptide array approach uncovers
association sites within the JNK/ b -arrestin signalling complex. FEBS Lett . 2009;
583:3310- 3316.
76. Miller WE, McDonald PH, Cai SF, Field ME, Davis RJ, Lefkowitz RJ. Identification
of a motif in the carboxyl terminus of b -arrestin2 responsible for activation of JNK3.
J Biol Chem . 2001;276:27770- 27777.
77. Lynch MJ, Baillie GS, Mohamed A, et al. RNA silencing identifies PDE4D5 as the
functionally relevant cAMP phosphodiesterase interacting with b -arrestin to control
the protein kinase A/AKAP79-mediated switching of the b 2-adrenergic receptor to
activation of ERK in HEK293B2 cells. J Biol Chem . 2005;280:33178- 33189.
78. Shenoy SK, McDonald PH, Kohout TA, Lefkowitz RJ. Regulation of receptor fate by
ubiquitination of activated

b 2-adrenergic receptor and b -arrestin. Science . 2001;

294:1307- 1313.
79. Mangmool S, Shukla AK, Rockman HA. b -Arrestin-dependent activation of Ca2 þ /
calmodulin kinase II after b -adrenergic receptor stimulation. J Cell Biol . 2010;189:
573- 587.